AGIO vs INSP

AGIO exhibits severe financial instability as evidenced by a critical Piotroski F-Score of 1/9, indicating a significant deterioration in fundamental health. While the company maintains an exceptionally strong liquidity position (Current Ratio 11.46) and minimal debt, it is plagued by massive operating losses (-608.89% margin) and an astronomical Price-to-Sales ratio of 30.88. Despite strong top-line revenue growth of 86.10% and bullish analyst targets, the combination of consistent earnings misses, bearish insider selling by the CEO and CFO, and a failing deterministic scorecard suggests the stock is fundamentally overvalued and high-risk.

INSP exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity 0.04). While the stock has suffered a severe multi-year price collapse, it is currently trading almost exactly at its Graham Number ($54.84), suggesting it has reached a defensive valuation floor. The massive disconnect between the current price ($55.11) and the growth-based intrinsic value ($144.25), coupled with explosive earnings growth (308.4% YoY), presents a compelling value-growth opportunity. Despite bearish technicals and insider selling, the underlying profitability and liquidity metrics are superior to sector averages.